IntraLinks announces alliance with Schulman Associates IRB

IntraLinks clinical trial workspaces now contain an SAIRB template for potential investigators to utilize when submitting their credentials for review by SAIRB.

By Editor on Dec 10, 2002

IntraLinks clinical trial workspaces now contain an SAIRB template for potential investigators to utilize when submitting their credentials for review by SAIRB. IntraLinks will also allow SAIRB to communicate IRB approvals to investigators and sponsors electronically.

As a national independent IRB, we were looking for a system that allows us to communicate efficiently with investigators and sponsors, said John Isidor, JD, CEO of SAIRB. IntraLinks allows potential investigators to exchange information with SAIRB online, making the entire process more time and cost efficient.

IntraLinks is committed to creating a drug development hub that helps all of the parties involved in conducting a clinical trial," said Richard Jenkins, General Manager of Life Sciences at IntraLinks. "Our alliance with SAIRB provides us with yet another link to an integral component of the process and enhances the benefits of IntraLinks for our pharmaceutical clients. By using IntraLinks, SAIRB will have new tools to manage and track submissions regarding new and amended protocols which will enhance efficiencies in IRB processing time and reduce the number of days needed to complete study start up.